RIBOMETRIX
Ribometrix is a platform therapeutics company that discovers small molecule drugs that target functional 3D RNA structures to treat human diseases. Our scientific offices are located in the newly renovated Biolabs Space in Durham, with offices in Chapel Hill and Boston.
RIBOMETRIX
Social Links:
Industry:
Biotechnology Health Care Life Science Pharmaceutical
Founded:
2014-01-01
Address:
Greenville, South Carolina, United States
Country:
United States
Website Url:
http://www.ribometrix.com
Total Employee:
11+
Status:
Active
Contact:
(252) 551-1088
Email Addresses:
[email protected]
Total Funding:
45.3 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Google Maps Microsoft Azure DNS Google Maps API Amazon Ohio Region DreamHost Hosting Dreamhost DNS
Similar Organizations
Apic Bio
Apic Bio is a gene therapy company that develops treatment options for rare, undertreated neurological and liver diseases.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Current Advisors List
Current Employees Featured
Founder
Investors List
Illumina Ventures
Illumina Ventures investment in Venture Round - Ribometrix
MP Healthcare Venture Management
MP Healthcare Venture Management investment in Venture Round - Ribometrix
Dementia Discovery Fund
Dementia Discovery Fund investment in Venture Round - Ribometrix
AbbVie Biotech Ventures
AbbVie Biotech Ventures investment in Series A - Ribometrix
Illumina Ventures
Illumina Ventures investment in Series A - Ribometrix
SV Health Investors
SV Health Investors investment in Series A - Ribometrix
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - Ribometrix
Pappas Capital
Pappas Capital investment in Series A - Ribometrix
Amgen Ventures
Amgen Ventures investment in Series A - Ribometrix
Hatteras Venture Partners
Hatteras Venture Partners investment in Series A - Ribometrix
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-21 | Ribometrix Promotes Dr. Manjunath Ramarao to Chief Scientific Officer |
Official Site Inspections
http://www.ribometrix.com Semrush global rank: 5.57 M Semrush visits lastest month: 1.52 K
- Host name: a1c452a94fd604445.awsglobalaccelerator.com
- IP address: 15.197.235.107
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Ribometrix"
The Next Frontier of Drug Discovery | Ribometrix
Ribometrix is leading a new drug-discovery paradigm: using small molecules to target RNA biology and prevent the production of proteins that drive disease. Unlike conventional …See details»
A Company on the Cutting-Edge - Ribometrix
May 24, 2023 · Ribometrix is a drug-discovery company leading a new paradigm in small molecule therapeutics that modulate RNA biology. Our industry-leading drug discovery …See details»
Meet Our Team of Experts at Ribometrix | Ribometrix
May 24, 2023 · Discover the science, people, and opportunities at Ribometrix. Collaborative, solutions-focused team with diverse skills, perspectives, and ideas. Decades of drug …See details»
Ribometrix - Crunchbase Company Profile & Funding
Ribometrix is a platform therapeutics company that discovers small molecule drugs that target functional 3D RNA structures to treat human diseases. Our scientific offices are located in the newly renovated Biolabs Space in Durham, …See details»
Ribometrix - The Org
Ribometrix, headquartered in Durham, North Carolina, is a biotechnology company leveraging world-leading expertise in three-dimensional structural analysis of RNA as the foundation of its …See details»
Ribometrix Inc. | LinkedIn
Ribometrix is a platform therapeutics company discovering small molecule drugs that target functional 3D RNA structures to treat human diseases. Our scientific offices are located in the newly...See details»
Ribometrix Company Profile 2024: Valuation, Funding …
Operator of a biotechnology company intended to lead a new paradigm in small molecule therapeutics that modulate ribonucleic acid biology.See details»
Ribometrix raises $30 million to target RNA with small …
Nov 14, 2018 · Ribometrix is the latest biotech start-up to raise cash for a bold, but increasingly popular, idea in drug discovery: target RNA with small-molecule drugs.See details»
Working at Ribometrix Inc. - Great Place To Work®
Ribometrix leverages its world-leading expertise in three-dimensional RNA structural analysis to identify novel small molecules that inhibit the production of disease-associated proteins.See details»
An Industry-Leading Drug Discovery Platform
Ribometrix has built an industry-leading technology platform that leverages proprietary capabilities to identify and drug complex RNA structures in therapeutically compelling RNAs. Our platform has revealed that many of …See details»
Ribometrix Promotes Dr. Manjunath Ramarao to Chief …
Mar 21, 2022 · DURHAM, N.C.-- ( BUSINESS WIRE )-- Ribometrix, a biotechnology company developing small molecule therapeutics that target RNA to treat human diseases, announced today the promotion of Manjunath...See details»
Ribometrix Announces Collaboration with Genentech to Discover …
Jan 6, 2021 · DURHAM, N.C.-- ( BUSINESS WIRE )-- Ribometrix, Inc ., today announced a strategic collaboration with Genentech, a member of the Roche Group, to discover and …See details»
Ribometrix LLC - VentureRadar
Website: http://www.ribometrix.com/ Develops small molecule drugs targeting functional 3D RNA structures to treat diseases, utilizing specialized technologies to discover therapeutic RNAs …See details»
Vertex, Ribometrix to develop RNA-targeted small molecules
Oct 6, 2019 · Vertex Pharmaceuticals will pay Ribometrix $20 million to develop up to three RNA-targeted small-molecule treatments.See details»
A History of Thinking Differently | Ribometrix
Ribometrix was founded on a big idea: build a proprietary drug discovery platform based on novel RNA structure determination technology to discover and develop small molecule therapeutics …See details»
Ribometrix Signs Blockbuster Deal with Genentech
Jan 6, 2021 · Genentech, a member of the Roche Group, will pay Ribometrix a $25 million upfront payment for exclusive rights to certain novel, small-molecule therapeutics against several …See details»
Genentech taps Ribometrix for drugs that target RNA
Jan 8, 2021 · A computer model of a small molecule (blue) binding to a pocket formed by three-dimensional folding of an RNA molecule (gray) Genentech will collaborate with Ribometrix to …See details»
Inside potential $1B deal for Ribometrix: A look at startup’s science ...
Jan 12, 2021 · Ribometrix, a Durham company specializing in RNA-based therapeutics, has formed a drug discovery and development collaboration with Genentech that could be worth …See details»
The Key Steps in Our Pipeline for Discovery | Ribometrix
Learn more about our platform for discovering and developing small-molecule drugs that modulate RNA biology. Be on the cutting edge of RNA biology modulation. Check out our current …See details»
Ribometrix Signs Major R&D Deal, Gains New Funding, Names …
Sep 30, 2019 · Ribometrix, a Durham company specializing in RNA-based therapeutics, will partner with Vertex Pharmaceuticals of Boston to discover and develop drug candidates for …See details»